Differences in collagen content, orientation, distribution, structures, and type play a critical role in prostate cancer progression, demonstrating, by gene expression, that the amount of COL1A1 increased in cancer tissue compared to COL3A1. The gene discussed is COL3A1; the disease is prostate carcinoma.